Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases
Open Access
- 1 October 1979
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 22 (10) , 1060-1063
- https://doi.org/10.1002/art.1780221003
Abstract
Sera from patients with systemic lupus erythematosus (SLE) and clinically related diseases were examined for cold-reactive lymphocytotoxic antibodies (LCA). The incidence of LCA was significantly increased in SLE (93%), discoid lupus (50%), and “lupuslike” syndromes associated with congenital complement deficiencies (63%) as compared to normal controls (3%) and patients with drug-induced lupus (11%), mixed connective tissue disease (MCTD) (17%), and necrotizing vasculitis (19%). The diagnostic and pathogenetic implications of these differences are discussed.This publication has 17 references indexed in Scilit:
- LYMPHOCYTOTOXIC ANTIBODIES IN FAMILY MEMBERS OF PATIENTS WITH MULTIPLE SCLEROSISThe Lancet, 1978
- ANA-negative systemic lupus erythematosusThe American Journal of Medicine, 1978
- Lymphocytotoxic antibodiesArthritis & Rheumatism, 1977
- Lymphocytotoxic antibodies in sle patients and their relativesArthritis & Rheumatism, 1976
- Family Distribution of Lymphocytotoxins in Hodgkin's DiseaseAnnals of Internal Medicine, 1976
- Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1975
- Nature of cold‐reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosusArthritis & Rheumatism, 1975
- Cytotoxins in DiseaseNew England Journal of Medicine, 1970
- Lymphocyte Cytotoxic Antibodies in Systemic Lupus ErythematosusNature, 1970
- Microdroplet Assay of Human Serum CytotoxinsNature, 1964